查看購物車
  • English
  • Japanese
  • Korean
本報告分析了胃癌治療市場規模及預測（2021-2034年），包括全球及區域市場佔有率、趨勢和成長機會。分析範圍：按類型、治療方法、給藥途徑、分銷管道和地區分類。
市場調查報告書
商品編碼
2070315

本報告分析了胃癌治療市場規模及預測（2021-2034年），包括全球及區域市場佔有率、趨勢和成長機會。分析範圍：按類型、治療方法、給藥途徑、分銷管道和地區分類。

Stomach Cancer Therapeutics Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Treatment, Route of Administration, Distribution Channel, and Geography
出版日期: | 出版商: The Insight Partners | 英文 341 Pages | 訂單完成後即時交付

價格

預計胃癌治療市場將從 2025 年的 53.2 億美元成長到 2034 年的 144.6 億美元，2026 年至 2034 年的複合年成長率為 11.76%。

全球胃癌發生率的上升、PD-1/PD-L1查核點抑制劑聯合治療的快速普及以及基於生物標記的檢測和伴隨診斷的擴展，都是推動胃癌治療市場成長的重要因素。此外，抗體藥物複合體（ADC）的廣泛應用以增強腫瘤靶向性、雙靶點和雙特異性免疫療法的興起，以及人工智慧和多組體學在個人化治療路徑中的全面應用，預計將在不久的將來為胃癌治療市場帶來新的趨勢。

胃癌的發生與發展涉及多種基因組、轉錄組、蛋白質組和表觀遺傳因素，因此其生物學行為十分複雜，導致標準治療方法往往難以取得足夠的療效。透過整合多組體學，研究人員可以全面了解腫瘤的生物學特徵，從而識別出關鍵的生物標記物，例如HER2、PD-L1和CLDN18.2，這些標記是醫生選擇標靶治療時所依據的。借助人工智慧，研究人員可以分析龐大的多組體學資料集，發現其中的規律並預測治療結果。利用人工智慧模型，研究人員可以根據生物標記水平和分子特徵對患者進行分類，從而確定是選擇抗體偶聯藥物（ADC）療法還是免疫療法。目前，機器學習技術正在為ADC的研發提供支持，透過篩選有效抗體、保持連接子穩定性並建立穩健的有效載荷，提高藥物設計的效率和臨床試驗的成功率。人工智慧驅動的臨床決策支援系統能夠幫助醫療專業人員利用患者的個別資訊（包括基因數據和治療史）來確定最有效的治療方案。這在胃癌中尤其重要，因為胃癌對HER2抑制劑和免疫查核點抑制劑等療法的抗藥性很常見。人工智慧系統透過持續學習來改進治療方案，並有助於開發更具適應性的治療方法。

人工智慧技術與多體學學研究的融合正在推動胃癌精準腫瘤學的發展。這使得醫生能夠做出更準確的診斷，並提供標靶治療，透過個人化治療方案改善患者預後，這正成為胃癌治療市場的一個重要趨勢。

按分銷管道分析

根據分銷管道，胃癌治療市場可分為醫院藥房、零售藥房和線上藥房。預計到2025年，醫院藥局將佔據胃癌治療市場最大的佔有率。醫院藥房負責配發昂貴且複雜的抗癌藥物，這些藥物需要在臨床環境中給藥。這些藥房透過其在醫院內的運營，與腫瘤科醫生、多學科腫瘤會診和輸液中心合作，提供化療、免疫療法和標靶治療。該系統在處理需要特殊儲存方法和持續患者監測的注射劑和腸外給藥藥物時尤其重要。醫院藥局透過處方藥清單的選擇、藥物安全監測和採購活動，管理先進療法的各個方面。市場擴張主要受三個因素驅動：胃癌病例的增加、腫瘤科的擴張以及需要臨床監督的生物製藥和精準藥物的日益普及。醫療保健政策、報銷制度和醫院癌症治療基礎設施的發展共同為該管道提供全面協調的治療服務奠定了堅實的基礎，從而推動了胃癌治療市場的成長。

目錄

第1章：執行摘要

第2章：胃癌治療藥物市場展望

  • 概述
  • 價值鏈分析
  • 供應鏈分析
  • 波特五力分析
  • PEST分析
  • 主要國家的進出口分析
    • 主要國家的進出口分析
  • 人工智慧（AI）的影響
  • 產品或技術藍圖
  • 永續發展與ESG趨勢
  • 專利分析
  • 法律規範

第3章 競爭情勢

  • 企業標竿分析：依主要公司分類
  • 2025年市佔率分析：依主要公司分類
  • 市場集中度

第4章：胃癌治療市場：關鍵產業動態

  • 市場促進因素
    • 全球胃癌發生率上升
    • PD-1/PD-L1查核點抑制劑在聯合治療。
    • 擴大基於生物標記的檢測和伴隨診斷
  • 市場限制因素
    • 高價標靶療法和免疫療法
    • 嚴重副作用會影響患者的耐受性和治療效果
    • 針對高級生物標記檢測的保險覆蓋範圍有限
  • 市場機遇
    • 向高成長新興市場進行地理多元化投資
    • 開發和大規模生產用於居家照護的口服製劑
    • 透過新輔助治療和輔助治療創新來管理早期胃癌。
  • 未來趨勢
    • 廣泛應用抗體藥物複合體（ADC）以增強腫瘤標靶化。
    • 雙靶點和雙特異性免疫療法的興起
    • 人工智慧和多組體學在個人化治療路徑中的全面應用
  • 促進因素和抑制因素的影響

第5章：胃癌治療市場：全球市場分析

第6章：胃癌治療市場收入分析：按類型分類

  • 胃癌藥物市場預測與分析：按類型分類
    • 腺癌
    • 消化器官系統腫瘤
    • 神經內分泌腫瘤
    • 淋巴瘤
    • 其他

第7章：胃癌​​治療市場收入分析：依治療方式分類

  • 胃癌藥物市場預測與分析：依治療類型分類
    • 標靶治療藥物和免疫治療藥物
    • 化療和合併用藥
    • 其他

第8章：胃癌治療市場收入分析：標靶治療和免疫治療藥物分類

  • 胃癌治療市場預測與分析：分子標靶藥物與免疫療法藥物
    • 人類表皮生長因子受體（HER2）
    • 單株抗體
    • 查核點抑制劑

第9章：胃癌治療市場收入分析：依給藥途徑分類

  • 胃癌藥物市場預測與分析：依給藥途徑分類
    • 口服
    • 腸外
    • 其他

第10章：胃癌治療藥物市場收入分析：依分銷管道分類

  • 胃癌治療市場預測與分析：依通路分類
    • 醫院藥房
    • 零售藥房
    • 網路藥房

第11章：胃癌治療市場：區域分析

  • 北美洲
    • 按類型
    • 按類型治療
    • 標靶治療藥物和免疫治療藥物
    • 透過行政途徑
    • 透過分銷管道
    • 美國市場
    • 加拿大市場
    • 墨西哥市場
  • 歐洲
    • 德國市場
    • 法國市場
    • 英國市場
    • 義大利市場
    • 西班牙市場
    • 其他歐洲市場
  • 亞太地區
    • 中國市場
    • 日本市場
    • 印度市場
    • 澳洲市場
    • 韓國市場
    • 其他亞太市場
  • 中東和非洲
    • 沙烏地阿拉伯市場
    • 南非市場
    • 阿拉伯聯合大公國市場
    • 其他中東和非洲市場
  • 中美洲和南美洲
    • 巴西市場
    • 阿根廷市場
    • 其他拉丁美洲市場

第12章：胃癌治療藥物市場趨勢

第13章：胃癌治療市場：主要公司概況

  • Merck & Co Inc
  • Bristol-Myers Squibb Co
  • Eli Lilly and Co
  • Astellas Pharma Inc
  • Genentech Inc
  • AstraZeneca Plc
  • Daiichi Sankyo Co Ltd
  • Celltrion Inc
  • Biocon Biologics Ltd
  • BeOne Medicines GmbH

第14章：其他分析公司列表

第15章附錄

Product Code: TIPRE00043151

The stomach cancer therapeutics market size is expected to grow from US$ 5.32 billion in 2025 to US$ 14.46 billion by 2034; it is projected to register a CAGR of 11.76% during 2026-2034.

The rising global incidence of stomach cancer, rapid uptake of PD-1/PD-L1 checkpoint inhibitors in combination regimens, and expansion of biomarker-driven testing and companion diagnostics are noteworthy factors contributing to the expansion of the stomach cancer therapeutics market size. Additionally, widespread integration of antibody-drug conjugates for enhanced tumor targeting, the rise of dual-target and bispecific immunotherapies, and full-scale adoption of AI and multiomics for personalized treatment pathways are projected to bring new stomach cancer therapeutics market trends in the near future.

Gastric cancer exhibits complex biological behavior because various genomic transcriptomic proteomic and epigenetic factors affect its development which makes standard treatment methods less successful. Through multiomics integration researchers gain complete tumor biological knowledge that enables them to find important biomarkers which include HER2 PD-L1 and CLDN18.2 that doctors use to select targeted therapies. AI enables researchers to examine extensive multiomics datasets which allow them to discover patterns and forecast treatment outcomes. AI models enable researchers to categorize patients based on their biomarker levels and molecular characteristics which allows them to choose between ADC treatments and immunotherapy treatments. Machine learning approaches currently assist researchers in ADC development because they help them select effective antibodies while maintaining stable linkers and creating powerful payloads which boosts drug design efficiency and clinical trial success rates. AI-based clinical decision support systems enable healthcare professionals to use patient-specific information which contains genetic data and treatment history to determine the most effective treatment options. This is particularly relevant in gastric cancer, where resistance to therapies like HER2 inhibitors or immune checkpoint inhibitors is common. AI systems improve treatment pathways through their continuous learning progress which helps develop adaptable therapy methods.

AI technology and multi-omics research work together to create precision oncology for gastric cancer which enables doctors to make better diagnoses and provide targeted treatments that lead to better patient results through customized treatment programs, thereby emerging as a significant trend in the stomach cancer therapeutics market.

Distribution Channel -Based Insights

Based on distribution channel, the stomach cancer therapeutics market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment held the largest stomach cancer therapeutics market share in 2025. Hospital pharmacies are responsible for dispensing expensive and intricate oncology medications which require clinical environments for their application. The pharmacies establish links with oncologists and multidisciplinary tumor boards and infusion centers through their hospital-based operations which handle chemotherapy and immunotherapy and targeted therapy treatments. The system shows its most value when it needs to handle injectable drugs and parenteral drugs which need special storage solutions and permanent patient observation. Hospital pharmacies manage all aspects of advanced therapeutic drugs through their work with formulary selection and pharmacovigilance and purchasing activities. The market expansion results from three factors which include increased stomach cancer cases and growing oncology departments and the rising use of biologics and precision medicines which need clinical oversight. The combination of healthcare policies and reimbursement systems and hospital cancer care infrastructure development establishes a strong foundation for this channel to provide complete and coordinated treatment services, thereby fueling the stomach cancer therapeutics market growth.

The World Health Organization and Australian Institute of Health and Welfare are among the primary and secondary sources referred to while preparing the stomach cancer therapeutics market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. Stomach Cancer Therapeutics Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
    • 2.2.1 Raw Materials/Components
    • 2.2.2 Manufacturing Process/Technology
    • 2.2.3 Distribution Landscape
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 Porter's Five Force Analysis
    • 2.4.1 Competitive Rivalry - High
    • 2.4.2 Bargaining Power of Suppliers - Moderate
    • 2.4.3 Bargaining Power of Buyers - High
    • 2.4.4 Threat of Substitutes - Moderate
    • 2.4.5 Threat of New Entrants - Low
  • 2.5 PEST Analysis
  • 2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
    • 2.6.1 Import-Export Analysis for Key Countries
  • 2.7 Impact of Artificial Intelligence (AI)
  • 2.8 Product or Technology Roadmap
  • 2.9 Sustainability and ESG Trends
    • 2.9.1 Environmental Trends
    • 2.9.2 Social Trends
    • 2.9.3 Governance Trends
  • 2.10 Patent Analysis
  • 2.11 Regulatory Framework

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis, 2025 - By Key Players
  • 3.3 Market Concentration

4. Stomach Cancer Therapeutics Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Global Incidence of Stomach Cancer
    • 4.1.2 Rapid Uptake of PD-1/PD-L1 Checkpoint Inhibitors in Combination Regimens
    • 4.1.3 Expansion of Biomarker-Driven Testing and Companion Diagnostics
  • 4.2 Market Restraints
    • 4.2.1 High Costs of Premium Targeted and Immunotherapy Drugs
    • 4.2.2 Serious Side Effects Impacting Patient Tolerance and Outcomes
    • 4.2.3 Limited Reimbursement for Advanced Biomarker Testing
  • 4.3 Market Opportunities
    • 4.3.1 Geographic Diversification into High-Growth Emerging Markets
    • 4.3.2 Development and Scaling of Oral Formulations for Home-Based Care
    • 4.3.3 Early-Stage Disease Management with Neoadjuvant and Adjuvant Innovations
  • 4.4 Future Trends
    • 4.4.1 Widespread Integration of Antibody-Drug Conjugates for Enhanced Tumor Targeting
    • 4.4.2 Rise of Dual-Target and Bispecific Immunotherapies
    • 4.4.3 Full-Scale Adoption of AI and Multi-Omics for Personalized Treatment Pathways
  • 4.5 Impact of Drivers and Restraints

5. Stomach Cancer Therapeutics Market - Global Market Analysis

  • 5.1 Stomach Cancer Therapeutics Market Revenue (US$ Million), 2021-2034
  • 5.2 Stomach Cancer Therapeutics Market Forecast and Analysis

6. Stomach Cancer Therapeutics Market Revenue Analysis - Type

  • 6.1 Stomach Cancer Therapeutics Market Forecasts and Analysis by Type
    • 6.1.1 Adenocarcinomas
      • 6.1.1.1 Overview
      • 6.1.1.2 Adenocarcinomas: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.2 Gastrointestinal Tumors
      • 6.1.2.1 Overview
      • 6.1.2.2 Gastrointestinal Tumors: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.3 Neuroendocrine Tumors
      • 6.1.3.1 Overview
      • 6.1.3.2 Neuroendocrine Tumors: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.4 Lymphoma
      • 6.1.4.1 Overview
      • 6.1.4.2 Lymphoma: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.5 Others
      • 6.1.5.1 Overview
      • 6.1.5.2 Others: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)

7. Stomach Cancer Therapeutics Market Revenue Analysis - Treatment

  • 7.1 Stomach Cancer Therapeutics Market Forecasts and Analysis by Treatment
    • 7.1.1 Targeted and Immunotherapy Drugs
      • 7.1.1.1 Overview
      • 7.1.1.2 Targeted and Immunotherapy Drugs: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.2 Chemotherapy and Combination Drugs
      • 7.1.2.1 Overview
      • 7.1.2.2 Chemotherapy and Combination Drugs: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.3 Others
      • 7.1.3.1 Overview
      • 7.1.3.2 Others: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)

8. Stomach Cancer Therapeutics Market Revenue Analysis - Targeted And Immunotherapy Drugs

  • 8.1 Stomach Cancer Therapeutics Market Forecasts and Analysis by Targeted And Immunotherapy Drugs
    • 8.1.1 Human Epidermal Growth Factor Receptor (HER2)
      • 8.1.1.1 Overview
      • 8.1.1.2 Human Epidermal Growth Factor Receptor (HER2): Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.2 Monoclonal Antibody
      • 8.1.2.1 Overview
      • 8.1.2.2 Monoclonal Antibody: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.3 Checkpoint Inhibitors
      • 8.1.3.1 Overview
      • 8.1.3.2 Checkpoint Inhibitors: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)

9. Stomach Cancer Therapeutics Market Revenue Analysis - Route Of Administration

  • 9.1 Stomach Cancer Therapeutics Market Forecasts and Analysis by Route Of Administration
    • 9.1.1 Oral
      • 9.1.1.1 Overview
      • 9.1.1.2 Oral: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)
    • 9.1.2 Parenteral
      • 9.1.2.1 Overview
      • 9.1.2.2 Parenteral: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)
    • 9.1.3 Others
      • 9.1.3.1 Overview
      • 9.1.3.2 Others: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)

10. Stomach Cancer Therapeutics Market Revenue Analysis - Distribution Channel

  • 10.1 Stomach Cancer Therapeutics Market Forecasts and Analysis by Distribution Channel
    • 10.1.1 Hospital Pharmacy
      • 10.1.1.1 Overview
      • 10.1.1.2 Hospital Pharmacy: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)
    • 10.1.2 Retail Pharmacy
      • 10.1.2.1 Overview
      • 10.1.2.2 Retail Pharmacy: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)
    • 10.1.3 Online Pharmacy
      • 10.1.3.1 Overview
      • 10.1.3.2 Online Pharmacy: Stomach Cancer Therapeutics Market - Revenue, 2021-2034 (US$ Million)

11. Stomach Cancer Therapeutics Market - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Stomach Cancer Therapeutics Market Overview
    • 11.1.2 North America: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 11.1.3 North America: Stomach Cancer Therapeutics Market - By Segmentation
      • 11.1.3.1 Type
      • 11.1.3.2 Treatment
      • 11.1.3.3 Targeted And Immunotherapy Drugs
      • 11.1.3.4 Route Of Administration
      • 11.1.3.5 Distribution Channel
    • 11.1.4 North America: Stomach Cancer Therapeutics Market Breakdown by Countries
      • 11.1.4.1 United States Market
        • 11.1.4.1.1 United States: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.1.4.1.2 United States: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.1.4.1.2.1 Type
          • 11.1.4.1.2.2 Treatment
          • 11.1.4.1.2.3 Targeted And Immunotherapy Drugs
          • 11.1.4.1.2.4 Route Of Administration
          • 11.1.4.1.2.5 Distribution Channel
      • 11.1.4.2 Canada Market
        • 11.1.4.2.1 Canada: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.1.4.2.2 Canada: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.1.4.2.2.1 Type
          • 11.1.4.2.2.2 Treatment
          • 11.1.4.2.2.3 Targeted And Immunotherapy Drugs
          • 11.1.4.2.2.4 Route Of Administration
          • 11.1.4.2.2.5 Distribution Channel
      • 11.1.4.3 Mexico Market
        • 11.1.4.3.1 Mexico: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.1.4.3.2 Mexico: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.1.4.3.2.1 Type
          • 11.1.4.3.2.2 Treatment
          • 11.1.4.3.2.3 Targeted And Immunotherapy Drugs
          • 11.1.4.3.2.4 Route Of Administration
          • 11.1.4.3.2.5 Distribution Channel
  • 11.2 Europe
    • 11.2.1 Europe Stomach Cancer Therapeutics Market Overview
    • 11.2.2 Europe: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 11.2.3 Europe: Stomach Cancer Therapeutics Market - By Segmentation
      • 11.2.3.1 Type
      • 11.2.3.2 Treatment
      • 11.2.3.3 Targeted And Immunotherapy Drugs
      • 11.2.3.4 Route Of Administration
      • 11.2.3.5 Distribution Channel
    • 11.2.4 Europe: Stomach Cancer Therapeutics Market Breakdown by Countries
      • 11.2.4.1 Germany Market
        • 11.2.4.1.1 Germany: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.2.4.1.2 Germany: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.2.4.1.2.1 Type
          • 11.2.4.1.2.2 Treatment
          • 11.2.4.1.2.3 Targeted And Immunotherapy Drugs
          • 11.2.4.1.2.4 Route Of Administration
          • 11.2.4.1.2.5 Distribution Channel
      • 11.2.4.2 France Market
        • 11.2.4.2.1 France: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.2.4.2.2 France: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.2.4.2.2.1 Type
          • 11.2.4.2.2.2 Treatment
          • 11.2.4.2.2.3 Targeted And Immunotherapy Drugs
          • 11.2.4.2.2.4 Route Of Administration
          • 11.2.4.2.2.5 Distribution Channel
      • 11.2.4.3 United Kingdom Market
        • 11.2.4.3.1 United Kingdom: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.2.4.3.2 United Kingdom: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.2.4.3.2.1 Type
          • 11.2.4.3.2.2 Treatment
          • 11.2.4.3.2.3 Targeted And Immunotherapy Drugs
          • 11.2.4.3.2.4 Route Of Administration
          • 11.2.4.3.2.5 Distribution Channel
      • 11.2.4.4 Italy Market
        • 11.2.4.4.1 Italy: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.2.4.4.2 Italy: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.2.4.4.2.1 Type
          • 11.2.4.4.2.2 Treatment
          • 11.2.4.4.2.3 Targeted And Immunotherapy Drugs
          • 11.2.4.4.2.4 Route Of Administration
          • 11.2.4.4.2.5 Distribution Channel
      • 11.2.4.5 Spain Market
        • 11.2.4.5.1 Spain: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.2.4.5.2 Spain: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.2.4.5.2.1 Type
          • 11.2.4.5.2.2 Treatment
          • 11.2.4.5.2.3 Targeted And Immunotherapy Drugs
          • 11.2.4.5.2.4 Route Of Administration
          • 11.2.4.5.2.5 Distribution Channel
      • 11.2.4.6 Rest of Europe Market
        • 11.2.4.6.1 Rest of Europe: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.2.4.6.2 Rest of Europe: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.2.4.6.2.1 Type
          • 11.2.4.6.2.2 Treatment
          • 11.2.4.6.2.3 Targeted And Immunotherapy Drugs
          • 11.2.4.6.2.4 Route Of Administration
          • 11.2.4.6.2.5 Distribution Channel
  • 11.3 Asia Pacific
    • 11.3.1 Asia Pacific Stomach Cancer Therapeutics Market Overview
    • 11.3.2 Asia Pacific: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 11.3.3 Asia Pacific: Stomach Cancer Therapeutics Market - By Segmentation
      • 11.3.3.1 Type
      • 11.3.3.2 Treatment
      • 11.3.3.3 Targeted And Immunotherapy Drugs
      • 11.3.3.4 Route Of Administration
      • 11.3.3.5 Distribution Channel
    • 11.3.4 Asia Pacific: Stomach Cancer Therapeutics Market Breakdown by Countries
      • 11.3.4.1 China Market
        • 11.3.4.1.1 China: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.3.4.1.2 China: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.3.4.1.2.1 Type
          • 11.3.4.1.2.2 Treatment
          • 11.3.4.1.2.3 Targeted And Immunotherapy Drugs
          • 11.3.4.1.2.4 Route Of Administration
          • 11.3.4.1.2.5 Distribution Channel
      • 11.3.4.2 Japan Market
        • 11.3.4.2.1 Japan: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.3.4.2.2 Japan: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.3.4.2.2.1 Type
          • 11.3.4.2.2.2 Treatment
          • 11.3.4.2.2.3 Targeted And Immunotherapy Drugs
          • 11.3.4.2.2.4 Route Of Administration
          • 11.3.4.2.2.5 Distribution Channel
      • 11.3.4.3 India Market
        • 11.3.4.3.1 India: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.3.4.3.2 India: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.3.4.3.2.1 Type
          • 11.3.4.3.2.2 Treatment
          • 11.3.4.3.2.3 Targeted And Immunotherapy Drugs
          • 11.3.4.3.2.4 Route Of Administration
          • 11.3.4.3.2.5 Distribution Channel
      • 11.3.4.4 Australia Market
        • 11.3.4.4.1 Australia: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.3.4.4.2 Australia: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.3.4.4.2.1 Type
          • 11.3.4.4.2.2 Treatment
          • 11.3.4.4.2.3 Targeted And Immunotherapy Drugs
          • 11.3.4.4.2.4 Route Of Administration
          • 11.3.4.4.2.5 Distribution Channel
      • 11.3.4.5 South Korea Market
        • 11.3.4.5.1 South Korea: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.3.4.5.2 South Korea: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.3.4.5.2.1 Type
          • 11.3.4.5.2.2 Treatment
          • 11.3.4.5.2.3 Targeted And Immunotherapy Drugs
          • 11.3.4.5.2.4 Route Of Administration
          • 11.3.4.5.2.5 Distribution Channel
      • 11.3.4.6 Rest of Asia Pacific Market
        • 11.3.4.6.1 Rest of Asia Pacific: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.3.4.6.2 Rest of Asia Pacific: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.3.4.6.2.1 Type
          • 11.3.4.6.2.2 Treatment
          • 11.3.4.6.2.3 Targeted And Immunotherapy Drugs
          • 11.3.4.6.2.4 Route Of Administration
          • 11.3.4.6.2.5 Distribution Channel
  • 11.4 Middle East and Africa
    • 11.4.1 Middle East and Africa Stomach Cancer Therapeutics Market Overview
    • 11.4.2 Middle East and Africa: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 11.4.3 Middle East and Africa: Stomach Cancer Therapeutics Market - By Segmentation
      • 11.4.3.1 Type
      • 11.4.3.2 Treatment
      • 11.4.3.3 Targeted And Immunotherapy Drugs
      • 11.4.3.4 Route Of Administration
      • 11.4.3.5 Distribution Channel
    • 11.4.4 Middle East and Africa: Stomach Cancer Therapeutics Market Breakdown by Countries
      • 11.4.4.1 Saudi Arabia Market
        • 11.4.4.1.1 Saudi Arabia: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.4.4.1.2 Saudi Arabia: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.4.4.1.2.1 Type
          • 11.4.4.1.2.2 Treatment
          • 11.4.4.1.2.3 Targeted And Immunotherapy Drugs
          • 11.4.4.1.2.4 Route Of Administration
          • 11.4.4.1.2.5 Distribution Channel
      • 11.4.4.2 South Africa Market
        • 11.4.4.2.1 South Africa: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.4.4.2.2 South Africa: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.4.4.2.2.1 Type
          • 11.4.4.2.2.2 Treatment
          • 11.4.4.2.2.3 Targeted And Immunotherapy Drugs
          • 11.4.4.2.2.4 Route Of Administration
          • 11.4.4.2.2.5 Distribution Channel
      • 11.4.4.3 United Arab Emirates Market
        • 11.4.4.3.1 United Arab Emirates: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.4.4.3.2 United Arab Emirates: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.4.4.3.2.1 Type
          • 11.4.4.3.2.2 Treatment
          • 11.4.4.3.2.3 Targeted And Immunotherapy Drugs
          • 11.4.4.3.2.4 Route Of Administration
          • 11.4.4.3.2.5 Distribution Channel
      • 11.4.4.4 Rest of Middle East and Africa Market
        • 11.4.4.4.1 Rest of Middle East and Africa: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.4.4.4.2 Rest of Middle East and Africa: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.4.4.4.2.1 Type
          • 11.4.4.4.2.2 Treatment
          • 11.4.4.4.2.3 Targeted And Immunotherapy Drugs
          • 11.4.4.4.2.4 Route Of Administration
          • 11.4.4.4.2.5 Distribution Channel
  • 11.5 South and Central America
    • 11.5.1 South and Central America Stomach Cancer Therapeutics Market Overview
    • 11.5.2 South and Central America: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 11.5.3 South and Central America: Stomach Cancer Therapeutics Market - By Segmentation
      • 11.5.3.1 Type
      • 11.5.3.2 Treatment
      • 11.5.3.3 Targeted And Immunotherapy Drugs
      • 11.5.3.4 Route Of Administration
      • 11.5.3.5 Distribution Channel
    • 11.5.4 South and Central America: Stomach Cancer Therapeutics Market Breakdown by Countries
      • 11.5.4.1 Brazil Market
        • 11.5.4.1.1 Brazil: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.5.4.1.2 Brazil: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.5.4.1.2.1 Type
          • 11.5.4.1.2.2 Treatment
          • 11.5.4.1.2.3 Targeted And Immunotherapy Drugs
          • 11.5.4.1.2.4 Route Of Administration
          • 11.5.4.1.2.5 Distribution Channel
      • 11.5.4.2 Argentina Market
        • 11.5.4.2.1 Argentina: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.5.4.2.2 Argentina: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.5.4.2.2.1 Type
          • 11.5.4.2.2.2 Treatment
          • 11.5.4.2.2.3 Targeted And Immunotherapy Drugs
          • 11.5.4.2.2.4 Route Of Administration
          • 11.5.4.2.2.5 Distribution Channel
      • 11.5.4.3 Rest of South and Central America Market
        • 11.5.4.3.1 Rest of South and Central America: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.5.4.3.2 Rest of South and Central America: Stomach Cancer Therapeutics Market - By Segmentation
          • 11.5.4.3.2.1 Type
          • 11.5.4.3.2.2 Treatment
          • 11.5.4.3.2.3 Targeted And Immunotherapy Drugs
          • 11.5.4.3.2.4 Route Of Administration
          • 11.5.4.3.2.5 Distribution Channel

12. Stomach Cancer Therapeutics Market Industry Landscape

13. Stomach Cancer Therapeutics Market - Key Company Profiles

  • 13.1 Merck & Co Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Bristol-Myers Squibb Co
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Eli Lilly and Co
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Astellas Pharma Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Genentech Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 AstraZeneca Plc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Daiichi Sankyo Co Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Celltrion Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Biocon Biologics Ltd
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 BeOne Medicines GmbH
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. List of Additional Companies Analyzed

  • 14.1 List of Additional Companies Analyzed

15. Appendix

  • 15.1 Glossary
  • 15.2 Research Methodology and Approach
    • 15.2.1 Secondary Research
    • 15.2.2 Primary Research
    • 15.2.3 Market Estimation Approach
      • 15.2.3.1 Supply Side Analysis
      • 15.2.3.2 Demand Side Analysis
    • 15.2.4 Research Assumptions and Limitations
    • 15.2.5 Currency Conversion
  • 15.3 About The Insight Partners
  • 15.4 Market Intelligence Cloud

List Of Tables

  • Table 1. List of Patents and Description
  • Table 2. List of Regulatory Bodies and Organizations
  • Table 3. Ease of Doing Business: Key Country Rankings
  • Table 4. Market Share Analysis, 2025 - By Key Players
  • Table 5. Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million)
  • Table 6. Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million)
  • Table 7. Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 8. Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 9. Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 10. Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 11. Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 12. Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 13. Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 14. Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 15. Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 16. Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 17. North America: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 18. North America: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 19. North America: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 20. North America: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 21. North America: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 22. North America: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 23. North America: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 24. North America: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 25. North America: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 26. North America: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 27. North America: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 28. North America: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 29. United States: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 30. United States: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 31. United States: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 32. United States: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 33. United States: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 34. United States: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 35. United States: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 36. United States: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 37. United States: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 38. United States: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 39. Canada: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 40. Canada: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 41. Canada: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 42. Canada: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 43. Canada: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 44. Canada: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 45. Canada: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 46. Canada: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 47. Canada: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 48. Canada: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 49. Mexico: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 50. Mexico: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 51. Mexico: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 52. Mexico: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 53. Mexico: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 54. Mexico: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 55. Mexico: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 56. Mexico: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 57. Mexico: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 58. Mexico: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 59. Europe: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 60. Europe: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 61. Europe: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 62. Europe: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 63. Europe: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 64. Europe: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 65. Europe: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 66. Europe: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 67. Europe: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 68. Europe: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 69. Europe: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 70. Europe: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 71. Germany: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 72. Germany: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 73. Germany: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 74. Germany: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 75. Germany: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 76. Germany: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 77. Germany: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 78. Germany: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 79. Germany: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 80. Germany: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 81. France: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 82. France: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 83. France: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 84. France: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 85. France: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 86. France: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 87. France: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 88. France: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 89. France: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 90. France: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 91. United Kingdom: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 92. United Kingdom: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 93. United Kingdom: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 94. United Kingdom: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 95. United Kingdom: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 96. United Kingdom: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 97. United Kingdom: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 98. United Kingdom: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 99. United Kingdom: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 100. United Kingdom: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 101. Italy: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 102. Italy: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 103. Italy: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 104. Italy: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 105. Italy: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 106. Italy: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 107. Italy: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 108. Italy: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 109. Italy: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 110. Italy: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 111. Spain: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 112. Spain: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 113. Spain: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 114. Spain: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 115. Spain: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 116. Spain: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 117. Spain: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 118. Spain: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 119. Spain: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 120. Spain: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 121. Rest of Europe: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 122. Rest of Europe: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 123. Rest of Europe: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 124. Rest of Europe: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 125. Rest of Europe: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 126. Rest of Europe: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 127. Rest of Europe: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 128. Rest of Europe: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 129. Rest of Europe: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 130. Rest of Europe: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 131. Asia Pacific: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 132. Asia Pacific: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 133. Asia Pacific: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 134. Asia Pacific: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 135. Asia Pacific: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 136. Asia Pacific: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 137. Asia Pacific: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 138. Asia Pacific: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 139. Asia Pacific: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 140. Asia Pacific: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 141. Asia Pacific: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 142. Asia Pacific: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 143. China: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 144. China: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 145. China: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 146. China: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 147. China: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 148. China: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 149. China: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 150. China: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 151. China: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 152. China: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 153. Japan: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 154. Japan: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 155. Japan: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 156. Japan: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 157. Japan: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 158. Japan: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 159. Japan: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 160. Japan: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 161. Japan: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 162. Japan: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 163. India: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 164. India: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 165. India: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 166. India: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 167. India: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 168. India: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 169. India: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 170. India: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 171. India: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 172. India: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 173. Australia: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 174. Australia: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 175. Australia: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 176. Australia: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 177. Australia: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 178. Australia: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 179. Australia: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 180. Australia: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 181. Australia: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 182. Australia: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 183. South Korea: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 184. South Korea: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 185. South Korea: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 186. South Korea: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 187. South Korea: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 188. South Korea: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 189. South Korea: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 190. South Korea: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 191. South Korea: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 192. South Korea: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 193. Rest of Asia Pacific: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 194. Rest of Asia Pacific: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 195. Rest of Asia Pacific: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 196. Rest of Asia Pacific: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 197. Rest of Asia Pacific: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 198. Rest of Asia Pacific: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 199. Rest of Asia Pacific: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 200. Rest of Asia Pacific: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 201. Rest of Asia Pacific: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 202. Rest of Asia Pacific: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 203. Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 204. Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 205. Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 206. Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 207. Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 208. Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 209. Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 210. Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 211. Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 212. Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 213. Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 214. Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 215. Saudi Arabia: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 216. Saudi Arabia: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 217. Saudi Arabia: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 218. Saudi Arabia: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 219. Saudi Arabia: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 220. Saudi Arabia: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 221. Saudi Arabia: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 222. Saudi Arabia: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 223. Saudi Arabia: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 224. Saudi Arabia: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 225. South Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 226. South Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 227. South Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 228. South Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 229. South Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 230. South Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 231. South Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 232. South Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 233. South Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 234. South Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 235. United Arab Emirates: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 236. United Arab Emirates: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 237. United Arab Emirates: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 238. United Arab Emirates: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 239. United Arab Emirates: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 240. United Arab Emirates: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 241. United Arab Emirates: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 242. United Arab Emirates: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 243. United Arab Emirates: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 244. United Arab Emirates: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 245. Rest of Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 246. Rest of Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 247. Rest of Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 248. Rest of Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 249. Rest of Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 250. Rest of Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 251. Rest of Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 252. Rest of Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 253. Rest of Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 254. Rest of Middle East and Africa: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 255. South and Central America: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 256. South and Central America: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 257. South and Central America: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 258. South and Central America: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 259. South and Central America: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 260. South and Central America: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 261. South and Central America: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 262. South and Central America: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 263. South and Central America: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Distribution Channel
  • Table 264. South and Central America: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Distribution Channel
  • Table 265. South and Central America: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 266. South and Central America: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 267. Brazil: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Type
  • Table 268. Brazil: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Type
  • Table 269. Brazil: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Treatment
  • Table 270. Brazil: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Treatment
  • Table 271. Brazil: Stomach Cancer Therapeutics Market - Revenue, 2021-2025 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 272. Brazil: Stomach Cancer Therapeutics Market - Revenue Forecast, 2026-2034 (US$ Million) - by Targeted And Immunotherapy Drugs
  • Table 273. Brazil: Stomach Cancer Therapeutic

List Of Figures

  • Figure 1. Stomach Cancer Therapeutics Market Segmentation.
  • Figure 2. Stomach Cancer Therapeutics Market - Value Chain Analysis
  • Figure 3. Porter's Five Forces Analysis
  • Figure 4. Pest Analysis
  • Figure 5. Stomach Cancer Therapeutics Market - Key Industry Dynamics
  • Figure 6. Impact Analysis of Drivers and Restraints
  • Figure 7. Stomach Cancer Therapeutics Market Revenue (US$ Million), 2021-2034
  • Figure 8. Stomach Cancer Therapeutics Market Share (%) - by Type (2025 and 2034)
  • Figure 9. Adenocarcinomas: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 10. Gastrointestinal Tumors: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 11. Neuroendocrine Tumors: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 12. Lymphoma: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 13. Others: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 14. Stomach Cancer Therapeutics Market Share (%) - by Treatment (2025 and 2034)
  • Figure 15. Targeted and Immunotherapy Drugs: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 16. Chemotherapy and Combination Drugs: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 17. Others: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 18. Stomach Cancer Therapeutics Market Share (%) - by Targeted And Immunotherapy Drugs (2025 and 2034)
  • Figure 19. Human Epidermal Growth Factor Receptor (HER2): Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 20. Monoclonal Antibody: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 21. Checkpoint Inhibitors: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 22. Stomach Cancer Therapeutics Market Share (%) - by Route Of Administration (2025 and 2034)
  • Figure 23. Oral: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 24. Parenteral: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 25. Others: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 26. Stomach Cancer Therapeutics Market Share (%) - by Distribution Channel (2025 and 2034)
  • Figure 27. Hospital Pharmacy: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 28. Retail Pharmacy: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 29. Online Pharmacy: Stomach Cancer Therapeutics Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 30. Stomach Cancer Therapeutics Market Breakdown by Geography, 2025 and 2034
  • Figure 31. North America: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 32. North America: Stomach Cancer Therapeutics Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 33. United States: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 34. Canada: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 35. Mexico: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 36. Europe: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 37. Europe: Stomach Cancer Therapeutics Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 38. Germany: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 39. France: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 40. United Kingdom: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 41. Italy: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 42. Spain: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 43. Rest of Europe: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 44. Asia Pacific: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 45. Asia Pacific: Stomach Cancer Therapeutics Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 46. China: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 47. Japan: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 48. India: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 49. Australia: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 50. South Korea: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 51. Rest of Asia Pacific: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 52. Middle East and Africa: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 53. Middle East and Africa: Stomach Cancer Therapeutics Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 54. Saudi Arabia: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 55. South Africa: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 56. United Arab Emirates: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 57. Rest of Middle East and Africa: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 58. South and Central America: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 59. South and Central America: Stomach Cancer Therapeutics Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 60. Brazil: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 61. Argentina: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 62. Rest of South and Central America: Stomach Cancer Therapeutics Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 63. Bottom-Up Approach and Top-Down Approach